IRIDEX CORP Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2026-04-03: Federal exemption Rule 506(b); Types of securities offered Equity; Debt; OptionToAcquire; Date of first sale 2025-03-19; Total offering amount $20,000,000.
- 2025-04-03: Federal exemption Rule 506(b); Types of securities offered Equity; Debt; OptionToAcquire; Date of first sale 2025-03-19; Total offering amount $20,000,000.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2026-04-03 D/A | Rule 506(b) | Equity; Debt; OptionToAcquire | 2025-03-19 | $20,000,000 | $10,000,000 | $10,000,000 | 1 |
| 2025-04-03 | Rule 506(b) | Equity; Debt; OptionToAcquire | 2025-03-19 | $20,000,000 | $10,000,000 | $10,000,000 | 1 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |